Published in Br Med J (Clin Res Ed) on May 16, 1981
Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun (1983) 8.49
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun (1993) 3.04
Interpretation of the contraindications to whooping cough vaccination. Br Med J (Clin Res Ed) (1981) 2.10
Indications and contraindications for vaccines used in the Expanded Programme on Immunization. Bull World Health Organ (1984) 1.99
Pertussis immunisation and serious acute neurological illnesses in children. BMJ (1993) 1.71
Heatstroke as a possible cause of encephalopathy in infants. Br Med J (Clin Res Ed) (1983) 1.52
Reye's syndrome in children under three years old. Arch Dis Child (1982) 1.50
Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map. J Exp Med (1989) 1.49
Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough. Infect Immun (1990) 1.44
Pertussis toxin is required for pertussis vaccine encephalopathy. Proc Natl Acad Sci U S A (1985) 1.31
Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G. J Exp Med (1990) 1.30
Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen. Infect Immun (1990) 1.19
Uptake of pre-school immunization in a rural practice. J R Coll Gen Pract (1983) 1.18
Pertussis: the disease and new diagnostic methods. Clin Microbiol Rev (1988) 1.16
Maintenance of biological activity of pertussis toxin radioiodinated while bound to fetuin-agarose. Infect Immun (1987) 1.14
Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome. Am J Public Health (1987) 1.09
The past, present, and future of pertussis. The role of adults in epidemiology and future control. West J Med (1989) 1.07
Effect of lymphocytosis-promoting factor from Bordetella pertussis on cerebellar cyclic GMP levels. Infect Immun (1982) 1.05
Incidence, aetiology, and outcome of non-traumatic coma: a population based study. Arch Dis Child (2001) 1.03
Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit. Proc Natl Acad Sci U S A (1989) 1.03
Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein. Infect Immun (1994) 1.02
Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule. Infect Immun (1992) 1.02
In support of a compensation plan for vaccine-associated injuries. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. CMAJ (1986) 0.97
MHC-restricted recognition of immunogenic T cell epitopes of pertussis toxin reveals determinants in man distinct from the ADP-ribosylase active site. J Exp Med (1988) 0.96
Pertussis vaccine: myths and realities. Can Fam Physician (1988) 0.95
The severity of whooping cough in hospitalised children--is it declining? J Hyg (Lond) (1985) 0.92
Risk and pertussis vaccine. Arch Dis Child (1986) 0.90
Pertussis vaccine and encephalopathy after the Loveday trial. CMAJ (1988) 0.89
Pertussis in a rural area of Kenya: epidemiology and results of a vaccine trial. Bull World Health Organ (1984) 0.85
Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange. BMC Microbiol (2012) 0.83
Bordetella pertussis adenylate cyclase: isolation and purification by calmodulin-sepharose 4B chromatography. Infect Immun (1987) 0.83
Toxicity of pertussis vaccine. Br Med J (Clin Res Ed) (1982) 0.83
Active and passive immunizations with Bordetella colonization factor A protect mice against respiratory challenge with Bordetella bronchiseptica. Infect Immun (2008) 0.83
Pertussis vaccine. Br Med J (Clin Res Ed) (1981) 0.82
Detection of antibodies inhibiting the ADP-ribosyltransferase activity of pertussis toxin in human serum. J Clin Microbiol (1992) 0.79
Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine. Sci Rep (2016) 0.78
Monoclonal antibodies that inhibit ADP-ribosyltransferase but not NAD-glycohydrolase activity of pertussis toxin. Infect Immun (1990) 0.78
Interactive effects of pertussis toxin and the phorbol ester tumour promotor, phorbol dibutyrate, on T-lymphocyte mitogenesis and the expression of phenotypic determinants. Immunology (1989) 0.78
Pertussis toxin-induced alterations of murine hepatic drug metabolism following administration of diphtheria and tetanus toxoids and pertussis vaccine adsorbed. Infect Immun (1993) 0.77
Pertussis and pertussis vaccine. Can Med Assoc J (1985) 0.77
Case-control study on encephalopathy associated with diphtheria-tetanus immunization in Campania, Italy. Bull World Health Organ (1985) 0.76
Immunization in Canada: current controversies. Can Fam Physician (1985) 0.75
Benefits and risks of childhood immunisations in developing countries. Br Med J (Clin Res Ed) (1987) 0.75
First year fits. Br Med J (Clin Res Ed) (1985) 0.75
The pertussis vaccine controversy. Public Health Rep (1984) 0.75
Pertussis: the disease and the vaccine. Can Fam Physician (1986) 0.75
Whooping cough immunization in France and Britain: discussion paper. J R Soc Med (1983) 0.75
Whooping cough: a shot in the dark. Br Med J (Clin Res Ed) (1983) 0.75
How are the sub-unit pertussis vaccines to be evaluated? Epidemiol Infect (1987) 0.75
Pertussis: should we immunise neurologically disabled and developmentally delayed children? Br Med J (Clin Res Ed) (1983) 0.75
Fractional doses of DPT vaccine. CMAJ (1986) 0.75
DTP and SIDS: when data differ. Am J Public Health (1987) 0.75
Immunisation practice and policy. J Epidemiol Community Health (1984) 0.75
The British Paediatric Surveillance Unit: the first 20 years. Arch Dis Child (2007) 0.75
Estimation of relative risk from individually matched series. Biometrics (1970) 6.47
Neurological complications of pertussis inoculation. Arch Dis Child (1974) 6.12
Vaccination against whooping-cough. Efficacy versus risks. Lancet (1977) 5.25
Pertussis vaccination. Dev Med Child Neurol (1974) 3.26
Discrepancies in immunization records. Community Med (1980) 2.85
Osteomalacia in rheumatoid arthritis. Ann Rheum Dis (1980) 2.21
Cigarette smoking in pregnancy: its influence on birth weight and perinatal mortality. Br Med J (1972) 7.69
Prostitution and risk of HIV: female prostitutes in London. BMJ (1993) 6.06
Biochemical properties of hormone-sensitive adenylate cyclase. Annu Rev Biochem (1980) 3.79
Epidemiology of the Hong Kong-68 variant of influenza A2 in Britain. Br Med J (1971) 3.74
Inflammatory pseudotumors of the lung. Ann Thorac Surg (1999) 3.51
Poliomyelitis surveillance in England and Wales, 1965-8. Public Health (1970) 3.25
Facilities and diagnostic criteria in sexually transmitted disease clinics in England and Wales. Br J Vener Dis (1978) 3.21
Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA (1997) 3.18
Lobar torsion after pulmonary resection: presentation and outcome. J Thorac Cardiovasc Surg (2001) 3.16
Relationship between the beta-adrenergic receptor and adenylate cyclase. J Biol Chem (1977) 2.99
Regulation of Gi and Go by mastoparan, related amphiphilic peptides, and hydrophobic amines. Mechanism and structural determinants of activity. J Biol Chem (1990) 2.96
Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol (2000) 2.96
Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med (1991) 2.93
Discrepancies in immunization records. Community Med (1980) 2.85
Attendance at a London casualty department. J R Coll Gen Pract (1977) 2.84
Purification of the regulatory component of adenylate cyclase. Proc Natl Acad Sci U S A (1980) 2.81
Primary structure of elongation factor Tu from Escherichia coli. Proc Natl Acad Sci U S A (1980) 2.72
Reconstitution of hormone-sensitive adenylate cyclase activity with resolved components of the enzyme. J Biol Chem (1978) 2.64
Completeness of statutory notification for acute bacterial meningitis. Br Med J (1976) 2.58
Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J Biol Chem (1988) 2.45
Epilepsy in childhood: findings from the National Child Development Study. Br Med J (1980) 2.37
Asymptomatic bacteriuria in girl entrants to Dundee primary schools. Br Med J (1969) 2.32
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Resolution of some components of adenylate cyclase necessary for catalytic activity. J Biol Chem (1977) 2.20
Influenza in Britain 1967-68. J Hyg (Lond) (1969) 2.18
Phospholipase C-beta 1 is a GTPase-activating protein for Gq/11, its physiologic regulator. Cell (1992) 2.17
Bronchobiliary fistula: principles of management. Ann Thorac Surg (2000) 2.15
A pilot study of sexual lifestyle in a random sample of the population of Great Britain. AIDS (1989) 2.13
Reconstitution of agonist-stimulated phosphatidylinositol 4,5-bisphosphate hydrolysis using purified m1 muscarinic receptor, Gq/11, and phospholipase C-beta 1. J Biol Chem (1992) 2.06
Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med (1995) 2.05
Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol (1997) 2.05
Studies on the purification and properties of factor Tu from E. coli. Arch Biochem Biophys (1970) 2.02
Novel roles for saccharomyces cerevisiae mitotic spindle motors. J Cell Biol (1999) 1.99
Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells. Mol Endocrinol (2001) 1.96
Characterization of the yeast mitochondrial locus necessary for tRNA biosynthesis: DNA sequence analysis and identification of a new transcript. Cell (1983) 1.93
The cytosensor microphysiometer: biological applications of silicon technology. Science (1992) 1.93
Reconstitution of catecholamine-stimulated guanosinetriphosphatase activity. Biochemistry (1983) 1.87
Aetiology of Reye's syndrome. Arch Dis Child (1983) 1.86
RNA editing by cytidine insertion in mitochondria of Physarum polycephalum. Nature (1991) 1.85
Early and long-term results of prosthetic chest wall reconstruction. J Thorac Cardiovasc Surg (1999) 1.83
Rotavirus serotypes 6 and 10 predominate in cattle. J Clin Microbiol (1990) 1.81
Regulation of phospholipase C-beta1 by Gq and m1 muscarinic cholinergic receptor. Steady-state balance of receptor-mediated activation and GTPase-activating protein-promoted deactivation. J Biol Chem (1996) 1.80
Whooping cough and whooping cough vaccine: the risks and benefits debate. Epidemiol Rev (1982) 1.79
Localization and surgical treatment of occult insulinomas. Ann Surg (1990) 1.76
Total recovery studies of nonabsorbable indicators in the rat small intestine. Gastroenterology (1970) 1.76
A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound Med Biol (1996) 1.74
Behavioral intervention to improve calorie intake of children with cystic fibrosis: treatment versus wait list control. J Pediatr Gastroenterol Nutr (1996) 1.70
Trace chemistries of fire: a source of chlorinated dioxins. Science (1980) 1.69
Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology (1992) 1.66
Reconstitutively active G protein-coupled receptors purified from baculovirus-infected insect cells. J Biol Chem (1991) 1.63
Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity. J Neurosci (1998) 1.62
The effect of activating ligands on the intrinsic fluorescence of guanine nucleotide-binding regulatory proteins. J Biol Chem (1987) 1.61
Rapid GTP binding and hydrolysis by G(q) promoted by receptor and GTPase-activating proteins. Proc Natl Acad Sci U S A (1999) 1.61
Insulinomas: localization with selective intraarterial injection of calcium. Radiology (1991) 1.58
Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent primary hyperparathyroidism. Ann Surg (1992) 1.57
Gastrinomas: localization by means of selective intraarterial injection of secretin. Radiology (1990) 1.56
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring. BMJ (1988) 1.55
Catecholamine-stimulated GTPase cycle. Multiple sites of regulation by beta-adrenergic receptor and Mg2+ studied in reconstituted receptor-Gs vesicles. J Biol Chem (1986) 1.54
Photometric detection of ATP release from human erythrocytes exposed to ultrasonically activated gas-filled pores. Ultrasound Med Biol (1980) 1.53
Heatstroke as a possible cause of encephalopathy in infants. Br Med J (Clin Res Ed) (1983) 1.52
The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling. J Biol Chem (1998) 1.51
Estrogen and progesterone receptors in the normal female breast. Cancer Res (1991) 1.50
Relationship between fetal acidemia at cordocentesis and subsequent neurodevelopment. Ultrasound Obstet Gynecol (1992) 1.50
Convulsive disorders in British children. Proc R Soc Med (1973) 1.50
Reye's syndrome in children under three years old. Arch Dis Child (1982) 1.50
Society of Cardiovascular & Interventional Radiology position statement on radiation safety. J Vasc Interv Radiol (2001) 1.48
Video-assisted thoracic surgery in trauma patients. J Am Coll Surg (1997) 1.46
Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg (2001) 1.45
Investigation of cavitation in flowing media by lithotripter shock waves both in vitro and in vivo. Ultrasound Med Biol (1989) 1.44
Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol Biol Cell (1999) 1.42
PDZ domain proteins: scaffolds for signaling complexes. Curr Biol (1997) 1.42
Hong Kong influenza in the Royal Air Force 1968-70. J Hyg (Lond) (1973) 1.41
Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study Group. Respir Med (2000) 1.41
Reconstitution of catecholamine-sensitive adenylate cyclase activity: interactions of solubilized components with receptor-replete membranes. Proc Natl Acad Sci U S A (1977) 1.41
Surgical treatment of primary lung cancer with synchronous brain metastases. J Thorac Cardiovasc Surg (2001) 1.41
Ivor Lewis esophagogastrectomy for esophageal cancer. Ann Thorac Surg (2001) 1.39
Occlusive peripheral vascular disease: a multicenter trial of fluorescence-guided, pulsed dye laser-assisted balloon angioplasty. Radiology (1991) 1.39
Paediatric manpower. Arch Dis Child (1982) 1.39
Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. Am J Respir Crit Care Med (2001) 1.39
beta-Adrenergic receptor: ligand binding properties and the interaction with adenylyl cyclase. Adv Cyclic Nucleotide Res (1977) 1.38
Membership of the Faculty of Public Health Medicine: the new Part I examination. J Public Health Med (1992) 1.38
Palmitoylation of a conserved cysteine in the regulator of G protein signaling (RGS) domain modulates the GTPase-activating activity of RGS4 and RGS10. J Biol Chem (1999) 1.38
Vector-host studies of an epizootic of Venezuelan equine encephalomyelitis in Guatemala, 1969. Am J Epidemiol (1971) 1.37
Serological evidence of infection with A2 Hong Kong influenza virus during the epidemic in Britain 1968-9. Br Med J (1969) 1.37
Elongation factor Tu and the aminoacyl-tRNA-EFTu-GTP complex. Methods Enzymol (1974) 1.36
A mutation that alters the nucleotide specificity of elongation factor Tu, a GTP regulatory protein. J Biol Chem (1987) 1.36
Chylothorax. Semin Respir Crit Care Med (2001) 1.35
Determining skin thickness with pulsed ultra sound. J Invest Dermatol (1979) 1.35
Metabolism of basic amino acids in Pseudomonas putida. Catabolism of lysine by cyclic and acyclic intermediates. J Biol Chem (1971) 1.34
ICRP PUBLICATION 120: Radiological protection in cardiology. Ann ICRP (2013) 1.33
The amino acid sequence of elongation factor Tu of Escherichia coli. The complete sequence. J Biol Chem (1981) 1.33
Chimeric muscarinic cholinergic: beta-adrenergic receptors that activate Gs in response to muscarinic agonists. J Biol Chem (1990) 1.32
Survey of antibiotic prescribing in a district general hospital. I. Pattern of use. Lancet (1981) 1.31